| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 56,240 | 51,310 | 54,998 | 59,322 | | Cost of Revenue | 22,532 | 22,226 | 25,772 | 27,897 | | | Gross Profit | 33,708 | 29,084 | 29,226 | 31,425 | | | Operating Expenses | | Research Development | 8,678 | 9,345 | 10,326 | 9,942 | | Selling General and Administrative | 19,269 | 21,685 | 21,269 | 25,670 | | Non Recurring |
-
|
-
|
-
| 14,406 | | Others | 121 | 174 | 173 | 175 | | | | Total Operating Expenses |
-
|
-
|
-
| 50,193 | | | | Operating Income or Loss | 5,640 | (2,120) | (2,542) | (18,768) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 643 | 494 | (88) | 920 | | Earnings Before Interest And Taxes | 6,283 | (1,626) | (2,630) | (17,848) | | Interest Expense | 321 | 324 | 303 | 297 | | Income Before Tax | 5,962 | (1,950) | (2,933) | (18,145) | | Income Tax Expense | 1,208 | (525) | (268) | 966 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,754 | (1,425) | (2,665) | (19,111) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,754 | (1,425) | (2,665) | (19,111) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,754 | ($1,425) | ($2,665) | ($19,111) |
|
0.51% Nasdaq 
Income Statement
